MaxCyte Share News (MXCT)

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 18 April UnileverQ1 ResultsPZ CussonsTrading SolutionsTrading 19 events

MaxCyte Launches ExPERT Cellular Engineering Technology Platform

LONDON (Alliance News) - MaxCyte Inc on Monday announced the launch of its new ExPERT technology platform for use in cellular engineering.MaxCyte also noted that its business had produced

MaxCyte launches new generation of cellular engineering instruments

(Sharecast News) - MaxCyte on Monday launched its ExPERT technology platform, a family of instruments that are the next generation of its complex cellular engineering technology.

MaxCyte Inks Multi-Drug Clinical And Commercial Agreement With Kite

LONDON (Alliance News) - Biotechnology company MaxCyte Inc on Friday said it has expanded its business relationship with Kite by signing a multi-drug clinical and commercial agreement.Under

UPDATE: MaxCyte Placing Fully Subscribed; Raises Over GBP10.0 Million (ALLISS)

LONDON (Alliance News) - MaxCyte Inc on Tuesday said it has raised GBP10.0 million from a placing of 5.9 million shares at 170 pence each.The life sciences company placed 5.9 million just

MaxCyte To Raise At Least GBP10 Million For Future Growth Plans (ALLISS)

LONDON (Alliance News) - MaxCyte Inc on Tuesday said it plans to raise at least GBP10 million via a placing of shares in order to accelerate its growth strategy.The life sciences company no

MaxCyte Guides For Revenue Growth And Earnings Above Expectations

LONDON (Alliance News) - MaxCyte Inc on Tuesday guided for a 19% increase in its 2018 revenue with the firm expecting its annual earnings to exceed market views.The life science company in

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 25 OctoberGreen & Smart WoodsAlumasc GroupFriday 26 OctoberArgos Capital

MaxCyte Begins Patient Trial Of Proposed Cancer Treatment MCY-M11

LONDON (Alliance News) - Life sciences and medicines company MaxCyte Inc on Wednesday said it has dosed the first patient in its phase I trial for MCY-M11.MCY-M11 is a mesothelin targeting

MaxCyte Interim Revenue Rises But Loss Widens On CARMA Development

LONDON (Alliance News) - MaxCyte Inc on Monday said its loss widened in the first half of 2018 as it continued to invest in the development of its CARMA drug platform.The life sciences said

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 18 September Ocado GroupTrading Statement DP PolandHalf Year Year Year Year

DIRECTOR DEALINGS: Wife Of MaxCyte Non-Executive Director Buys Shares

LONDON (Alliance News) - Medical & technology company MaxCyte Inc said that Karin Johnston, wife of Non-Executive Director John Johnston, purchased 11,500 shares at a price of 240 pence per on

MaxCyte Hires Claudio Dansky Ullmann As New Chief Medical Officer

LONDON (Alliance News) - Cell-based medicine and life science company MaxCyte Inc on Wednesday announced the appointment of Claudio Dansky Ullmann as its new chief medical officer.Dansky be

MaxCyte Revenue Up But Loss Widens On Investments In CARMA Platform

LONDON (Alliance News) - MaxCyte Inc on Wednesday reported revenue growth in its recently finished financial year, but its loss significantly widened on spending on its cell a

MaxCyte Expects 2016 Pretax Loss To Be Better Than Market Expectations